Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
The IMAGINE Study
NCT06979323Phase 3Recruiting
- Sponsor
- GSK
- Start
- Jul 2024
- Primary completion
- Jan 2028
- Modality
- Monoclonal Antibodies
- Countries
- 12
01
Overview
A Phase 3 trial of depemokimab in asthma, sponsored by GSK. Started Jul 2024; status: recruiting.
02
Drugs
depemokimab
03
Conditions
asthma
Beyond the preview
Go deeper on NCT06979323.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06979323.